Bloomberg Technology
@bloombergtech·728K subscribers·13.9K videos
Juno Therapeutics CEO Bishop on Immunotherapy
Posted
January 9, 2017
Views
2,564
Likes
15
Comments
2
Engagement
0.66%
January 9, 2017
2,564
15
2
0.66%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
6:25Now PlayingJan.09 -- Juno Therapeutics CEO Hans Bishop discusses the company's immunotherapy for cancer. He speaks with Erik Schatzker on "Bloomberg Technology" from the JPMorgan Healthcare Conference.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
